Market sentiment tracking places the ITRM stock forecast in a cautiously optimistic zone, with projected earnings per share trending closer to breakeven over the next fiscal year. This aligns with upward revisions in analyst recommendations. For the upcoming trading day on Tuesday, 21st we expect Iterum Therapeutics Plc to open at $1.54, and during the day (based on 14 day Average True Range), to move between $1.37 and $1.71, which gives a possible trading interval of +/-$0.173 (+/-11.24%) up or down from last closing price. If Iterum Therapeutics Plc takes out the full calculated poss... This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies. In recent sessions, the ITRM stock forecast has been buoyed by increased bid sizes, indicating accumulating positions by mid-tier funds. Price volatility remains below the biotech sector average, indicating stable investor behavior.
